Pharmacokinetics, pharmacogenetics and optimisation of treatment with non-nucleoside reverse transcriptase inhibitors in HIV-infected African children
Efavirenz and nevirapine are the most widely used agents for treatment of HIV in children. Sources of variability in their pharmacokinetics and its association with virological outcome and adverse events in African children are poorly characterised, thereby limiting treatment optimisation. To fill t...
Main Author: | Bienczak, Andrzej Marek |
---|---|
Other Authors: | Denti, Paolo |
Format: | Doctoral Thesis |
Language: | English |
Published: |
University of Cape Town
2017
|
Subjects: | |
Online Access: | http://hdl.handle.net/11427/25063 |
Similar Items
-
Pharmacogenomics and pharmacokinetics of antiretroviral drugs and their associations with metabolic complications in HIV-infected Black South Africans
by: Sinxadi, Phumla Z
Published: (2016) -
Intracellular phosphorylation of nucleoside reverse transcriptase inhibitors
by: Sales, Sean Douglas
Published: (2000) -
The pharmacokinetics of lopinavir in HIV-infected adults receiving rifampicin with adjusted doses of lopinavir
by: Decloedt, Eric Hermann
Published: (2015) -
Lipidic strategy for improving bioavailability of nucleoside HIV reverse transcriptase inhibitor
by: N. S. Shastina, et al.
Published: (2011-04-01) -
Focus on Chirality of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors
by: Valeria Famiglini, et al.
Published: (2016-02-01)